These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 19463443)

  • 1. Early- and long-term intravascular ultrasound and angiographic findings after bioabsorbable magnesium stent implantation in human coronary arteries.
    Waksman R; Erbel R; Di Mario C; Bartunek J; de Bruyne B; Eberli FR; Erne P; Haude M; Horrigan M; Ilsley C; Böse D; Bonnier H; Koolen J; Lüscher TF; Weissman NJ;
    JACC Cardiovasc Interv; 2009 Apr; 2(4):312-20. PubMed ID: 19463443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
    Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease.
    Waseda K; Miyazawa A; Ako J; Hasegawa T; Tsujino I; Sakurai R; Yock PG; Honda Y; Kandzari DE; Leon MB; Fitzgerald PJ;
    JACC Cardiovasc Interv; 2009 Aug; 2(8):779-84. PubMed ID: 19695548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optical coherence tomography and intravascular ultrasound imaging of bioabsorbable magnesium stent degradation in porcine coronary arteries.
    Slottow TL; Pakala R; Okabe T; Hellinga D; Lovec RJ; Tio FO; Bui AB; Waksman R
    Cardiovasc Revasc Med; 2008; 9(4):248-54. PubMed ID: 18928950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial evidence for the return of coronary vasoreactivity following the absorption of bioabsorbable magnesium alloy coronary stents.
    Ghimire G; Spiro J; Kharbanda R; Roughton M; Barlis P; Mason M; Ilsley C; Di Mario C; Erbel R; Waksman R; Dalby M
    EuroIntervention; 2009 Jan; 4(4):481-4. PubMed ID: 19284070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First clinical evaluation of a luminal self-expanding shield in patients with intermediate coronary lesions.
    Granada JF; Milewski K; Uribe MP; Moncada M; Fernandez A; Blanco G; Kaluza GL; Wykrzykowska JJ; Serruys PW; Stone GW; Delgado JA
    EuroIntervention; 2011 Nov; 7(7):780-8. PubMed ID: 22082574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous coronary revascularization using a trilayer metal phosphorylcholine-coated zotarolimus-eluting stent.
    Abizaid A; Lansky AJ; Fitzgerald PJ; Tanajura LF; Feres F; Staico R; Mattos L; Abizaid A; Chaves A; Centemero M; Sousa AG; Sousa JE; Zaugg MJ; Schwartz LB
    Am J Cardiol; 2007 May; 99(10):1403-8. PubMed ID: 17493469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents.
    Roy P; Steinberg DH; Sushinsky SJ; Okabe T; Pinto Slottow TL; Kaneshige K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Weissman NJ; Lindsay J; Waksman R
    Eur Heart J; 2008 Aug; 29(15):1851-7. PubMed ID: 18550555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of left main coronary artery bifurcation lesions treated with biolimus-eluting DEVAX AXXESS plus nitinol self-expanding stent: intravascular ultrasound results of the AXXENT trial.
    Hasegawa T; Ako J; Koo BK; Miyazawa A; Sakurai R; Chang H; Dens J; Verheye S; Grube E; Honda Y; Fitzgerald PJ
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):34-41. PubMed ID: 19089934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeat stenting for the prevention of the early lumen loss phenomenon in patients with in-stent restenosis. Angiographic and intravascular ultrasound findings of a randomized study.
    Alfonso F; García P; Fleites H; Pimentel G; Sabaté M; Hernández R; Escaned J; Bañuelos C; Pérez-Vizcayno MJ; Moreno R; Macaya C
    Am Heart J; 2005 Feb; 149(2):e1-8. PubMed ID: 15846250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term clinical and angiographic outcomes after implantation of sirolimus-eluting stents with a "modified mini-crush" technique in coronary bifurcation lesions.
    Yang HM; Tahk SJ; Woo SI; Lim HS; Choi BJ; Choi SY; Yoon MH; Park JS; Zheng M; Hwang GS; Kang SJ; Shin JH
    Catheter Cardiovasc Interv; 2009 Jul; 74(1):76-84. PubMed ID: 19360861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative vascular remodelling after implantation of bioabsorbable magnesium alloy stents in porcine coronary arteries: a randomised comparison with bare-metal and sirolimus-eluting stents.
    Maeng M; Jensen LO; Falk E; Andersen HR; Thuesen L
    Heart; 2009 Mar; 95(3):241-6. PubMed ID: 18723586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel fully bioabsorbable salicylate-based sirolimus-eluting stent.
    Jabara R; Pendyala L; Geva S; Chen J; Chronos N; Robinson K
    EuroIntervention; 2009 Dec; 5 Suppl F():F58-64. PubMed ID: 22100678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catheter-based delivery of fluid paclitaxel for prevention of restenosis in native coronary artery lesions after stent implantation.
    Herdeg C; Göhring-Frischholz K; Haase KK; Geisler T; Zürn C; Hartmann U; Wöhrle J; Nusser T; Dippon J; May AE; Gawaz M
    Circ Cardiovasc Interv; 2009 Aug; 2(4):294-301. PubMed ID: 20031731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Absorbable coronary stents. New promising technology].
    Erbel R; Böse D; Haude M; Kordish I; Churzidze S; Malyar N; Konorza T; Sack S
    Herz; 2007 Jun; 32(4):308-19. PubMed ID: 17607538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the safety and performance of the STENTYS self-expanding coronary stent in acute myocardial infarction: results from the APPOSITION I study.
    Amoroso G; van Geuns RJ; Spaulding C; Manzo-Silberman S; Hauptmann KE; Spaargaren R; García-García HM; Serruys PW; Verheye S
    EuroIntervention; 2011 Aug; 7(4):428-36. PubMed ID: 21764660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of bifurcation lesions treated with novel drug-eluting dedicated bifurcation stent system: intravascular ultrasound results of the AXXESS PLUS trial.
    Miyazawa A; Ako J; Hassan A; Hasegawa T; Abizaid A; Verheye S; McClean D; Neumann FJ; Grube E; Honda Y; Fitzgerald PJ
    Catheter Cardiovasc Interv; 2007 Dec; 70(7):952-7. PubMed ID: 18044777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The extent of late in-stent neointima formation is modified by treatment with pravastatin: a preliminary study with intravascular ultrasound.
    Prati F; Morocutti G; Bernardi G; Sommariva L; Tomai F; Pagano A; Parma A; Boccanelli A; Fioretti P
    Ital Heart J; 2002 Aug; 3(8):455-61. PubMed ID: 12407821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term vascular changes after drug-eluting stent implantation assessed by serial volumetric intravascular ultrasound analysis.
    Kang SJ; Park DW; Mintz GS; Lee SW; Kim YH; Lee CW; Han KH; Kim JJ; Park SW; Park SJ
    Am J Cardiol; 2010 May; 105(10):1402-8. PubMed ID: 20451685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.